1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Hospital Infection Prevention And Control Market
2.2. Global Hospital Infection Prevention And Control Market, By Infection Type, 2023 (US$ Million)
2.3. Global Hospital Infection Prevention And Control Market, By Product, 2023 (US$ Million)
2.4. Global Hospital Infection Prevention And Control Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Hospital Infection Prevention And Control Market: Competitive Analysis
3.1. Market Positioning of Key Hospital Infection Prevention And Control Market Vendors
3.2. Strategies Adopted by Hospital Infection Prevention And Control Market Vendors
3.3. Key Industry Strategies
4. Hospital Infection Prevention And Control Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Hospital Infection Prevention And Control Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Pneumonia
5.3.2. Urinary Tract Infection
5.3.3. Blood Stream Infection
5.3.4. Surgical Site Infection
5.3.5. MRSA
5.3.6. Others

6. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Infection Prevention Supplies
6.3.1.1. Disinfectants
6.3.1.1.1. Hand Disinfectants
6.3.1.1.2. Skin Disinfectants
6.3.1.1.3. Instrument Disinfectants
6.3.1.1.4. Surface Disinfectants
6.3.1.2. Protective Apparel & Textiles
6.3.1.2.1. Medical & Laboratory Gloves
6.3.1.2.1.1. Examination Gloves
6.3.1.2.1.2. Surgical Gloves
6.3.1.2.1.3. Laboratory Gloves
6.3.1.2.2. Surgical Drapes
6.3.1.2.2.1. Nonwoven Drapes
6.3.1.2.2.2. Plastic Drapes
6.3.1.2.2.3. Woven Drapes
6.3.1.2.3. Surgical Gowns
6.3.1.2.4. Patient Gowns
6.3.1.2.5. Surgical & Staff Face Masks
6.3.1.2.6. Other Protective Apparel & Textile
6.3.1.2.6.1. Disposable Staff Apparel
6.3.1.2.6.2. Disposable Towels & Bedding
6.3.1.3. Safety-Enhanced Medical Devices
6.3.1.3.1. Safety-Enhanced Syringes
6.3.1.3.1.1. Prefillable Syringes
6.3.1.3.1.2. Safety-Enhanced Clinical Syringes
6.3.1.3.2. Safety-Enhanced Catheters
6.3.1.3.2.1. IV Catheter
6.3.1.3.2.2. Urinary Catheter
6.3.1.3.3. Safety-Enhanced Blood Collection Tubes
6.3.1.3.4. Other Safety-Enhanced Medical Devices
6.3.1.4. Sterilization Supplies
6.3.1.4.1. Sterile Containers
6.3.1.4.2. Sterilization Wrap
6.3.1.4.3. Sterilization Indicators
6.3.1.5. Medical Waste Disposal Supplies
6.3.1.5.1. Medical Waste Disposal Containers
6.3.1.5.2. Medical Waste Disposal Accessories
6.3.2. Infection Prevention Equipment
6.3.2.1. Endoscope Reprocessors
6.3.2.2. Sterilization Equipment
6.3.2.2.1. Heat Sterilization
6.3.2.2.2. Low-Temperature Sterilization
6.3.2.2.3. Filtration Sterilization
6.3.2.2.4. Radiation Sterilization
6.3.2.3. Washing/Disinfecting Equipment
6.3.2.4. Other Infection Prevention Equipment
6.3.2.4.1. Infectious Waste Receptacles
6.3.2.4.2. Infectious Waste Processing Units
6.3.2.5. Infection Prevention Services
6.3.2.5.1. Medical Waste Disposal Services
6.3.2.5.2. Contract Sterilization Services


7. North America Hospital Infection Prevention And Control Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
7.3. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
7.4.Hospital Infection Prevention And Control Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
7.4.1.1.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
7.4.1.2.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
7.4.1.3.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)

8. UK and European Union Hospital Infection Prevention And Control Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.3. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.Hospital Infection Prevention And Control Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.1.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.2.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.3.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.4.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.5.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
8.4.1.6.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)

9. Asia Pacific Hospital Infection Prevention And Control Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.3. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.Hospital Infection Prevention And Control Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.1.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.2.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.3.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.4.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.5.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
9.4.1.6.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)

10. Latin America Hospital Infection Prevention And Control Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
10.3. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
10.4.Hospital Infection Prevention And Control Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
10.4.1.1.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
10.4.1.2.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
10.4.1.3.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)

11. Middle East and Africa Hospital Infection Prevention And Control Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
11.3. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
11.4.Hospital Infection Prevention And Control Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
11.4.1.1.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
11.4.1.2.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Hospital Infection Prevention And Control Market: By Infection Type, 2022-2032, USD (Million)
11.4.1.3.2. Hospital Infection Prevention And Control Market: By Product, 2022-2032, USD (Million)

12. Company Profile
12.1. 3M Company
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Ansell Ltd.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Becton, Dickinson and Company
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Belimed AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Bemis Company, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. B. Braun Melsungen AG
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Cantel Medical Corp.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Cardinal Health, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Covidien plc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Crosstex International, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Danaher Corp.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Diversey, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Getinge Group
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Johnson & Johnson
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Halyard Health, Inc.
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. MMM Group
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
12.17. Matachana Group
12.17.1. Company Overview
12.17.2. Financial Performance
12.17.3. Product Portfolio
12.17.4. Strategic Initiatives
12.18. Medivators, Inc.
12.18.1. Company Overview
12.18.2. Financial Performance
12.18.3. Product Portfolio
12.18.4. Strategic Initiatives
12.19. Purdue Pharma LP
12.19.1. Company Overview
12.19.2. Financial Performance
12.19.3. Product Portfolio
12.19.4. Strategic Initiatives
12.20. Sealed Air Corp.
12.20.1. Company Overview
12.20.2. Financial Performance
12.20.3. Product Portfolio
12.20.4. Strategic Initiatives
12.21. Semperit AG Holding
12.21.1. Company Overview
12.21.2. Financial Performance
12.21.3. Product Portfolio
12.21.4. Strategic Initiatives
12.22. Synergy Health plc.
12.22.1. Company Overview
12.22.2. Financial Performance
12.22.3. Product Portfolio
12.22.4. Strategic Initiatives
12.23. Terumo Corp.
12.23.1. Company Overview
12.23.2. Financial Performance
12.23.3. Product Portfolio
12.23.4. Strategic Initiatives
12.24. Olympus Corporation
12.24.1. Company Overview
12.24.2. Financial Performance
12.24.3. Product Portfolio
12.24.4. Strategic Initiatives
12.25. Xenex Disinfection Services Inc.
12.25.1. Company Overview
12.25.2. Financial Performance
12.25.3. Product Portfolio
12.25.4. Strategic Initiatives
12.26. STERIS
12.26.1. Company Overview
12.26.2. Financial Performance
12.26.3. Product Portfolio
12.26.4. Strategic Initiatives
12.27. ASP (Advanced Sterilization Products)
12.27.1. Company Overview
12.27.2. Financial Performance
12.27.3. Product Portfolio
12.27.4. Strategic Initiatives
12.28. Ecolab
12.28.1. Company Overview
12.28.2. Financial Performance
12.28.3. Product Portfolio
12.28.4. Strategic Initiatives
12.29. KCWW (Kimberly-Clark Worldwide, Inc.)
12.29.1. Company Overview
12.29.2. Financial Performance
12.29.3. Product Portfolio
12.29.4. Strategic Initiatives